Company Legal Name
Latest Valuation
Founded Year
Headquarter
HeartFlow, Inc. develops advanced diagnostic software that creates precise 3D coronary artery models from standard CT scans, enabling non-invasive assessment of arterial blockages and blood flow restrictions. Founded in 2007 and headquartered in Redwood City, California, the company has established itself as a pioneer in computational fluid dynamics applied to cardiovascular medicine. HeartFlow's technology transforms traditional cardiac imaging by providing clinicians with detailed, personalized coronary analysis without requiring invasive catheterization procedures. The company continues to expand its AI-driven platform capabilities while pursuing broader clinical adoption and regulatory approvals across global markets to revolutionize cardiovascular diagnostic workflows.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





